-
41
Integrins identified as potential prognostic markers in osteosarcoma through multi-omics and multi-dataset analysis
Published 2025-01-01“…Abstract Osteosarcoma represents 20% of primary malignant bone tumors globally. …”
Get full text
Article -
42
Identification of Common Oncogenic Genes and Pathways Both in Osteosarcoma and Ewing’s Sarcoma Using Bioinformatics Analysis
Published 2022-01-01“…This study was aimed at exploring common oncogenic genes and pathways both in osteosarcoma and Ewing’s sarcoma. Microarray data were obtained from the Gene Expression Omnibus (GEO) database. …”
Get full text
Article -
43
Association of JMJD2B and Hypoxia-Inducible Factor 1 Expressions with Poor Prognosis in Osteosarcoma
Published 2020-01-01“…This study is aimed at exploring the expression and prognostic significance of JMJD2B in osteosarcoma and its association with hypoxia-inducible factor 1 (HIF1). …”
Get full text
Article -
44
Vitamin D Receptor, Retinoid X Receptor, Ki-67, Survivin, and Ezrin Expression in Canine Osteosarcoma
Published 2012-01-01“…Canine osteosarcoma (OS) is an aggressive malignant bone tumor. …”
Get full text
Article -
45
NIR‐II AIEgens nanosystem for fluorescence and chemiluminescence synergistic imaging‐guided precise resection in osteosarcoma surgery
Published 2025-01-01Subjects: Get full text
Article -
46
GsMTx-4 venom toxin antagonizes biophysical modulation of metastatic traits in human osteosarcoma cells
Published 2025-03-01Subjects: Get full text
Article -
47
The Value of Immune-Related Genes Signature in Osteosarcoma Based on Weighted Gene Co-expression Network Analysis
Published 2021-01-01“…Background. Osteosarcoma (OS) is a serious malignant tumor that is more common in adolescents or children under 20 years of age. …”
Get full text
Article -
48
Systemic Inflammatory Markers for Predicting Overall Survival in Patients with Osteosarcoma: A Systematic Review and Meta-Analysis
Published 2021-01-01“…Inflammatory markers are associated with tumor genesis and progression, but their prognostic significance in osteosarcoma remains unclear. Therefore, we discussed the prognostic value of related inflammatory markers in osteosarcoma through a meta-analysis and systematic review. …”
Get full text
Article -
49
Single-cell profiling of SLC family transporters: uncovering the role of SLC7A1 in osteosarcoma
Published 2025-01-01Subjects: “…Osteosarcoma…”
Get full text
Article -
50
Manganese-pyrochloric acid photosensitizer nanocomplexes against osteosarcoma: achieving both high activatability and high effectiveness
Published 2025-02-01Subjects: Get full text
Article -
51
Iron oxide nanoparticles coated with bioactive materials: a viable theragnostic strategy to improve osteosarcoma treatment
Published 2025-01-01Subjects: Get full text
Article -
52
-
53
Comprehensive analysis of ESCRT transcriptome-associated signatures and identification of the regulatory role of LMO7-AS1 in osteosarcoma
Published 2025-01-01Subjects: “…Osteosarcoma…”
Get full text
Article -
54
Relaxin inhibits 177Lu-EDTMP associated cell death in osteosarcoma cells through notch-1 pathway
Published 2022-12-01Subjects: “…osteosarcoma…”
Get full text
Article -
55
-
56
Long-term Outcome of Vascularized Fibular Bone Graft Reconstruction for Upper Limb Osteosarcoma: A Case Report
Published 2024-06-01“…Introduction: Osteosarcoma is a primary malignant bone tumor. In older days, the mainstay treatment was used to be amputation of the affected extremity. …”
Get full text
Article -
57
A Rare Extraskeletal Osteosarcoma Appearing After 55 Years on a Large Stage 3 Burn Scar
Published 2018-01-01“…Fifty-five years after the injury, this patient developed a large extraosseous osteosarcoma on the scar.…”
Get full text
Article -
58
Content Determination of Active Component in Huangqi Yinyanghuo Group and Its Effects on hTERT and Bcl-2 Protein in Osteosarcoma
Published 2014-01-01“…To screen the optimal extraction process and content determination of active component of Huangqi Yinyanghuo group (HYG) and to study the effects of HYG on human telomerase reverse transcriptase (hTERT) and Bcl-2 protein in osteosarcoma (HOS) cells, providing the theoretical basis for clinical application of HYG in treatment of osteosarcoma, orthogonal design table L9(43) was used to design the extraction process of HYG, and icariin was taken as the investigation index to optimize the extraction process of HYG. 0.125, 0.25, 0.5, 1, 2, 4, and 8 μmol/L HYG were taken to act separately on logarithmic growth phase osteosarcoma HOS cells, CCK-8 assay was used to determine cell viability, and immunohistochemical SP assay was used to determine the expression of hTERT and Bcl-2 protein. …”
Get full text
Article -
59
Fabrication of a Porous Metal-Organic Framework with Polar Channels for 5-Fu Delivery and Inhibiting Human Osteosarcoma Cells
Published 2018-01-01“…Furthermore, as indicated by the MTT assay, this drug/MOF composite shows low toxicity toward the human normal cells and demonstrates obvious anticancer activity against the human osteosarcoma cell line MG63.…”
Get full text
Article -
60
The Prognostic Model Established by the Differential Expression Genes Based on CD8+ T Cells to Evaluate the Prognosis and the Response to Immunotherapy in Osteosarcoma
Published 2023-01-01“…Osteosarcoma (OS) is a malignant tumor with an extremely poor prognosis, especially in progressive patients. …”
Get full text
Article